A decent increase of about 29.89% in the sales to Rs. 326.96 millions was observed for the quarter ended March 2026. The sales figure stood at Rs. 251.73 millions during the year-ago period.The Net Loss for the quarter ended March 2026 is Rs. -35.65 millions as compared to Net Loss of Rs. -69.58 millions of corresponding quarter ended March 2025 Operating profit Margin for the quarter ended March 2026 improved to -8.99% as compared to -39.53% of corresponding quarter ended March 2025

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202603	202503	% Var	202603	202503	% Var	202603	202503	% Var
Sales	326.96	251.73	29.89	1016.95	919.97	10.54	1016.95	919.97	10.54
Other Income	7.27	14.22	-48.87	34.49	28.77	19.88	34.49	28.77	19.88
PBIDT	-8.99	-39.53	-77.26	60.68	-11.28	-637.94	60.68	-11.28	-637.94
Interest	2.24	2.14	4.67	8.59	5.65	52.04	8.59	5.65	52.04
PBDT	-11.23	-70.26	-84.02	52.09	-45.52	-214.43	52.09	-45.52	-214.43
Depreciation	18.56	20.23	-8.26	74.96	79.50	-5.71	74.96	79.50	-5.71
PBT	-29.79	-90.49	-67.08	-22.87	-125.02	-81.71	-22.87	-125.02	-81.71
TAX	5.86	-20.91	-128.02	-3.68	72.36	-105.09	-3.68	72.36	-105.09
Deferred Tax	1.77	-20.91	-108.46	-7.77	71.88	-110.81	-7.77	71.88	-110.81
PAT	-35.65	-69.58	-48.76	-19.19	-197.38	-90.28	-19.19	-197.38	-90.28
Equity	874.06	856.04	2.11	874.06	856.04	2.11	874.06	856.04	2.11
PBIDTM(%)	-2.75	-15.70	-82.49	5.97	-1.23	-586.66	5.97	-1.23	-586.66

JHS Svendgaard Laboratories Ltd.